COVID-19 multidisciplinary high dependency unit: the Milan model
| Autor: | Giorgio Bozzi, Anna Maria Oneta, Flora Peyvandi, Francesco Blasi, Francesco Amati, Edoardo Simonetta, Emilia Privitera, Andrea Gori, Marco Mantero, Chiara Abbruzzese, Maria Pappalettera, Marco Vicenzi, Francesca Minoia, Marta Di Pasquale, Paola Tagliabue, Giovanni Filocamo, Andrea Gramegna, Stefano Aliberti, Salvatore Alongi, Alice D'Adda |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pneumonia Viral Pulmonary disease Disease Review 030204 cardiovascular system & hematology 03 medical and health sciences Betacoronavirus 0302 clinical medicine Multidisciplinary approach medicine Infection control Humans 030212 general & internal medicine Intensive care medicine Pandemics lcsh:RC705-779 High dependency unit Inpatients business.industry SARS-CoV-2 Outbreak COVID-19 Disease Management lcsh:Diseases of the respiratory system Management Italy Healthcare settings business Coronavirus Infections |
| Zdroj: | Respiratory Research Respiratory Research, Vol 21, Iss 1, Pp 1-12 (2020) |
| ISSN: | 1465-993X |
| Popis: | COVID-19 is a complex and heterogeneous disease. The pathogenesis and the complications of the disease are not fully elucidated, and increasing evidence shows that SARS-CoV-2 causes a systemic inflammatory disease rather than a pulmonary disease. The management of hospitalized patients in COVID-19 dedicated units is advisable for segregation purpose as well as for infection control. In this article we present the standard operating procedures of our COVID-19 high dependency unit of the Policlinico Hospital, in Milan. Our high dependency unit is based on a multidisciplinary approach. We think that the multidisciplinary involvement of several figures can better identify treatable traits of COVID-19 disease, early identify patients who can quickly deteriorate, particularly patients with multiple comorbidities, and better manage complications related to off-label treatments. Although no generalizable to other hospitals and different healthcare settings, we think that our experience and our point of view can be helpful for countries and hospitals that are now starting to face the COVID-19 outbreak. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |